G Winde, B Reers, A Holzgreve, R Fischer, A Bohlmann, H Bünte
Index: Langenbecks Arch. Chir. 378(2) , 86-91, (1993)
Full Text: HTML
We report our results with abdominal rectopexy (modified Ripstein procedure, Ripstein/Corman) without resection of the colon in 63 patients using lyophylized dura-strips, Vicryl gauze or Dexon gauze, as the underlying fixation material for the mobilized rectum, presacral fascia and fixation suture material. Forty-five of 64 patients (71.4%) were reevaluated by proctoscopic examination and questioning; the mean follow-up time was 52.5 months (range 3-136 months). Postoperative mortality due to the method was 0%; the mortality was 1.6% (n = 1/63) in general for the first postoperative 30-day period as a result of cardiac complications. There were three complications (4.7%) the durating operation. Postoperative morbidity was 25.4% (16/63); infectious complications occurred in 12.7% (8/63) of cases, with one case of spontaneous closure of a pelvicutaneous fistula after intraoperative injury to the rectal wall. Full-thickness rectal prolapse appeared after rectopexy in 4.4% (2/45) (dura material alone) and mucosal prolapse was seen in 15.5% (7/45) of the follow-up group. Constipation was reduced by 28.6% (18/63) to 22.2% during the follow-up. Seventeen of 28 patients (60.7%) with incontinence showed an improvement; total continence was registered in 35.7% (10/28). The increase in continence as a result of abdominal rectopexy was significant (Wilcoxon, P = 0.05). The special aspects of being in an older age group, having a long history of procidentia, the number of deliveries, the length of the preoperative incontinence period all showed no influence on the postoperative degree of continence (Spearman's rank correlation). In 7/15 cases with persisting incontinence after rectopexy, postanal repair (Parks) was efficient in 7/7 cases leading to total or partial continence.(ABSTRACT TRUNCATED AT 250 WORDS)
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Fenaminosulf
CAS:140-56-7 |
C8H10N3NaO3S |
CYP2C9 genotype vs. metabolic phenotype for individual drug ...
2015-01-01 [PLoS ONE 10(3) , e0120403, (2015)] |
Experimental evaluation of a new composite mesh with the sel...
1994-03-01 [J. Biomed. Mater. Res. 28(3) , 373-5, (1994)] |
Safety evaluation of a triazine compound nitromezuril by ass...
2015-04-01 [Regul Toxicol Pharmacol 71(3) , 585-9, (2015)] |
The use of Dexon as a replacement for the calcaneal tendon i...
1985-03-01 [J. Bone Joint Surg. Br. 67(2) , 313-6, (1985)] |
Intestinal complications associated with use of the Dexon me...
1990-07-01 [Gynecol. Oncol. 38(1) , 146-8, (1990)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved